Evidence map›Paper›PMID 26621249›Full record

ArticlePharmacological research2016

PPARα in lysosomal biogenesis: A perspective.

Arunava Ghosh, Kalipada Pahan

Open access · greenAbstract readLetter
In one paragraph

Article in Pharmacological research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Proximal Tubule-Specific Genetic Deficiency of PPARα Worsens Systemic Lipid and Glucose Metabolism During Fasting.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Prospect of Muscle-Building Supplement HMB in Alzheimer's Disease.Journal of clinical & experimental immunology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Activation of PPARα Exhibits Therapeutic Efficacy in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. PPARα Between Aspirin and Plaque Clearance.Journal of Alzheimer's disease : JAD · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Arunava GhoshDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States.
Kalipada PahanDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States; Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, 820 South Damen Avenue, Chicago, IL,United States. Electronic address: Kalipada_Pahan@rush.edu.
Jesse Brown VA Medical Center · USRush University Medical Center · US

Funding

Cinnamon, CNTF and EAER01AT006681 · NCCIH · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2011 to 2015
$1.8M
RANTES and Eotaxin: New players in PD progressionR01NS083054 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2013 to 2017
$1.7M
Cinnamon and its metabolite sodium benzoate in ParkinsonismI01BX003033 · VA · JESSE BROWN VA MEDICAL CENTER · PI PAHAN, KALIPADA · 2016 to 2020
–
BLRD VA I01 BX003033NCCIH NIH HHS AT6681NCCIH NIH HHS R01 AT006681NINDS NIH HHS NS083054NINDS NIH HHS R01 NS083054
6 · The paper itself

Abstract

Lysosomes are membrane-bound vesicles containing hydrolytic enzymes, ubiquitously present in all eukaryotic cells. Classically considered to be central to the cellular waste management machinery, recent studies revealed the role of lysosomes in a wide array of cellular processes like, degradation, cellular development, programmed cell death, secretion, plasma membrane repair, nutritional responses, and lipid metabolism. We recently studied the regulation of TFEB, considered to be the master regulator of lysosomal biogenesis, by activation of peroxisomal proliferator activated receptor α (PPARα), one of the key regulators of lipid metabolism. In this article, we discuss how the recent finding could be put in to perspective with the previous findings that relate lysosomal biogenesis to lipid metabolism, and comment on the possibility of a bi-directional interplay between these two distinct cellular processes upon activation of PPARα.

Indexed as

Lipid MetabolismAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsHumansLysosomesPPAR alphaBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsPPAR alphaTFEB protein, humanFibrate drugsLipid metabolismLysosomal biogenesisPPARαTFEB

Identifiers

PMID26621249
PMCPMC4861553
OpenAlexW2181204835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.